Mayne Pharma Group Ltd. | Ownership
Companies that own Mayne Pharma Group Ltd.
Investors Mutual Ltd.
115,348,827
7.34%
-13,829,847
5.73%
08/31/2018
Yarra Funds Management Ltd.
76,453,002
4.87%
-2,716,804
4.57%
08/22/2017
Lazard Asset Management Pacific Co.
74,106,253
4.72%
-5,456,977
0.67%
06/05/2018
Antares Capital Partners Ltd.
40,473,919
2.58%
-561,885
5.03%
12/12/2016
The Vanguard Group, Inc.
35,949,837
2.29%
131,480
0%
07/31/2018
MLC Investments Ltd.
33,976,485
2.16%
0
0.64%
12/12/2016
Dimensional Fund Advisors LP
19,188,275
1.22%
2,283,876
0%
04/30/2018
APG Asset Management NV
17,333,427
1.1%
17,333,427
0.01%
03/31/2018
Australian Foundation Investment Co. Ltd. (Invt Mgmt)
15,833,001
1.01%
-4,528,237
0.28%
10/04/2017
Colonial First State Asset Management (Australia) Ltd.
14,353,702
0.91%
-49,677,945
0.04%
10/04/2017
| Address |
1538 Main North Road
Salisbury South Australia (SA) 5106
Australia
|
|
Employees
|
- |
| Website |
http://www.maynepharma.com |
| Updated |
07/08/2019 |
| Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. |
